Surgical and interventional therapies for pulmonary arterial hypertension

被引:14
|
作者
Olsson, JK
Zamanian, RT
Feinstein, JA
Doyle, RL
机构
[1] Stanford Univ, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Div Pediat Cardiol, Stanford, CA USA
[3] Stanford Univ, Sch Med, Vera M Wall Ctr Pulm Vasc Dis, Stanford, CA USA
关键词
pulmonary arterial hypertension; congenital heart disease; pulmonary thromboendarterectomy; lung and heart-lung transplantation; atrial septostomy;
D O I
10.1055/s-2005-916157
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Surgical and interventional therapies for pulmonary arterial hypertension (PAH) in appropriately selected patients have the potential to dramatically improve or, in some cases, cure PAH. These include atrial septostomy, a palliative procedure or bridge to transplantation in patients with refractory right heart failure, pulmonary thromboendarterectomy for pulmonary hypertension associated with chronic thromboembolic disease, and closure of congenital systemic-pulmonary shunts in patients with PAH but without significant pulmonary vascular disease. Lung transplantation should be considered for patients with all forms of PAH who demonstrate advanced or progressive disease.
引用
收藏
页码:417 / 428
页数:12
相关论文
共 50 条
  • [31] Percutaneous Interventional Therapies for the Treatment of Patients With Severe Pulmonary Hypertension
    Bhamra-Ariza, Paul
    Keogh, Anne M.
    Muller, David W. M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (07) : 611 - 618
  • [32] The role of riociguat in combination therapies for pulmonary arterial hypertension
    Rahaghi, Franck F.
    Trivieri, Maria Giovanna
    Sahay, Sandeep
    RESPIRATORY MEDICINE, 2023, 211
  • [33] Economic evaluation of oral therapies for pulmonary arterial hypertension
    Harnett, J
    Van, EA
    Schoeman, O
    VALUE IN HEALTH, 2006, 9 (03) : A124 - A124
  • [34] Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension
    Pan, Irene Z.
    Carey, Jessica R.
    Jacobs, Joshua A.
    Dechand, John
    Sessions, Joshua J.
    Sorensen, Teshia
    Penn, Brittany A.
    Mayeux, Jennalyn D.
    Hatton, Nathan D.
    Ryan, John J.
    FRONTIERS IN MEDICINE, 2020, 7
  • [35] A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension
    Omnia Azmy Nabeh
    Alaa I. Saud
    Basma Amin
    Amira Samy Khedr
    Alaa Amr
    Aml Medhat Faoosa
    Eshraka Esmat
    Yasmeen Magdy Mahmoud
    Aya Hatem
    Mariam Mohamed
    Alaa Osama
    Youssef Mohamed Amin Soliman
    Reem Ibrahim Elkorashy
    Soha Aly Elmorsy
    American Journal of Cardiovascular Drugs, 2024, 24 : 39 - 54
  • [36] Novel investigational therapies for treating pulmonary arterial hypertension
    Sardana, Mayank
    Moll, Matthew
    Farber, Harrison W.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (12) : 1571 - 1596
  • [37] New therapies in pulmonary arterial hypertension: Recent insights
    Guglielmi, Giulia
    Dimopoulos, Konstantinos
    Wort, S. John
    INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE, 2025, 19
  • [38] Standard Nonspecific Therapies in the Management of Pulmonary Arterial Hypertension
    Sauler, Maor
    Fares, Wassim H.
    Trow, Terence K.
    CLINICS IN CHEST MEDICINE, 2013, 34 (04) : 799 - +
  • [39] The use of pulmonary arterial hypertension therapies in Eisenmenger syndrome
    Arvanitaki, Alexandra
    Diller, Gerhard-Paul
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2021, 19 (12) : 1053 - 1061
  • [40] Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension
    Gerthoffer, William
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 16